The results indicated that high expression of AKAP12 was correlated with worse OS for colon adenocarcinoma (COAD) (p = 0.0055), glioblastoma multiforme (GBM) (p = 0.047), brain low-grade glioma (LGG) (p = 0.0041), mesothelioma (MESO) (p = 0.026), ovarian serous cystadenocarcinoma (OV) (p = 0.027), stomach adenocarcinoma (STAD) (p = 0.0021) (Figure 3A). This evidence concerns the gene AKAP12 and ovarian serous cystadenocarcinoma.